GB002, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT07181382) | GB002, Inc. | 2026-02-01 |
| Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) (NCT05934526) | GB002, Inc. | 2023-12-28 |
Track GB002, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.